EAACI和WAO严重过敏反应指南长期管理解读及证据分析  

Interpretation and Citation Analysis of Long-term Management in EAACI and WAO Clinical Guidelines for Anaphylaxis

作　　者：骆兵 张紫薇 葛卫红[1] 汪小海[3] LUO Bing;ZHANG Ziwei;GE Weihong;WANG Xiaohai(Department of Pharmacy,Nanjing Drum Tower Hospital Affiliated to Medical College of Nanjing University,Nanjing 210008,China;School of Basic Medicine and Clinical Pharmacy,China Pharmaceutical University,Nanjing 210009,China;Department of Anesthesiology,Taikang Xianlin Drum Tower Hospital Affiliated to Medical College of Nanjing University,Nanjing 210008,China)

机构地区：[1]南京大学医学院附属鼓楼医院药学部,南京210008 [2]中国药科大学基础医学与临床药学学院,南京210009 [3]南京大学医学院附属泰康仙林鼓楼医院麻醉科,南京210008

出　　处：《医药导报》2021年第11期1517-1522,共6页Herald of Medicine

摘　　要：严重过敏反应是一种在接触致敏物质后突发的、严重的、存在潜在致命风险的全身性过敏反应。2014年欧洲变态反应与临床免疫学会严重过敏反应指南(EAACI指南2014)和2020年世界过敏组织严重过敏反应指导意见(WAO指南2020)均强调严重过敏反应急救管理后长期管理的必要性。该文对长期管理部分内容和引文证据质量水平进行了解读,并补充了最新研究证据,以期为严重过敏反应的长期管理提供参考。Anaphylaxis is a sudden,severe and potentially fatal systemic allergic reaction after exposure to sensitizing substances.Both the 2014 EAACI guideline and the 2020 WAO guideline emphasized the need for long-term management after emergency management of anaphylaxis.In order to provide references for the long-term management of anaphylaxis,this paper interprets the contents of long-term management,compares the quality level of citation evidence,and adds the latest research evidence.

关 键 词：严重过敏反应 长期管理 指南 推荐意见 证据 

分 类 号：R969[医药卫生—药理学] R969[医药卫生—药学]